北京大学学报(医学版) ›› 2017, Vol. 49 ›› Issue (4): 643-647. doi: 10.3969/j.issn.1671-167X.2017.04.017

• 论著 • 上一篇    下一篇

氟比洛芬酯在经直肠超声引导前列腺穿刺疼痛控制中的应用

兰轲,杨文博,张晓威,白文俊,李清,徐涛△   

  1. (北京大学人民医院泌尿外科, 北京100044)
  • 出版日期:2017-08-18 发布日期:2017-08-18
  • 通讯作者: 徐涛 E-mail: xutao@medmail.com.cn

Application of flurbiprofen axetil in pain management associated during transrectal ultrasound-guided prostate biopsy

LAN Ke, YANG Wen-bo, ZHANG Xiao-wei, BAI Wen-jun, LI Qing, XU Tao△   

  1. (Department of Urology,Peking University People’s Hospital,Beijing 100044, China)
  • Online:2017-08-18 Published:2017-08-18
  • Contact: XU Tao E-mail: xutao@medmail.com.cn

摘要: 目的:探索氟比洛芬酯静脉应用能否减轻经直肠超声引导下前列腺穿刺引起的疼痛。方法:采用随机、对照研究方法,共入选81例于北京大学人民医院泌尿外科住院行经直肠超声引导下前列腺穿刺患者,随机分为3组 (每组27例), 分别是: 直肠内局部表面麻醉 (intrarectal local anesthesia,IRLA) 组:术前5 min 5% (0.05 g/L)利多卡因凝胶60 mg直肠内局部表面麻醉;氟比洛芬酯 (flurbiprofen axetil,FA) 组:术前1 h氟比洛芬酯静脉滴注 (1 mg/kg) ; IRLA+FA组 :术前5 min 5% 利多卡因凝胶60 mg直肠内局部表面麻醉,同时术前1 h氟比洛芬酯静脉滴注 (1 mg/kg)。使用视觉模拟评分表 (visual analogue scale,VAS) 评估超声探头插入肛门时 (VASⅠ)、 麻醉过程中 (VASⅡ)、 穿刺活检时 (VASⅢ)及术后20 min时(VASⅣ)的疼痛评分。使用单因素协方差分析比较3组间患者基线差异。疼痛评分的组间差异采用参数检验的单因素协方差分析。随后采用图基(Tukey)事后检验法进行各组间比较:P1 、P2、P3分别为IRLA组和FA组、 FA组和IRLA+FA组、IRLA组和IRLA +FA组的组间差异P值,P<0.05认为差异有统计学意义,其中组间两两比较采用Bonferroni方法调整检验水准 α=0.017。结果:所有患者未见严重的术后并发症。3组患者的基线数据差异无统计学意义, VASⅡ(5.7±2.2,3.0±1.5,3.3±1.9, P=0.012 ) 和 VASⅢ(6.7±2.3,3.0±2.1,2.9±1.6,P=0.001 ) 差异有统计学意义; VASⅠ(3.2±1.0,4.1±2.1,4.2±1.7,P=5.752 )和 VASⅣ ( 1.4±2.1,1.0±0.9,1.1±0.7,P=3.772)差异无统计学意义。两两组间差异,在VASⅣ( P1 =0.007,P2=5.655,P3=0.001 )和VASⅢ(P1 =0.008,P2=7.517,P3=0.001)方面,IRLA组和FA组、IRLA组和IRLA+FA组的组间差异有统计学意义。结论:氟比洛芬酯能安全、有效地减轻经直肠超声引导下的前列腺穿刺术患者的疼痛。

关键词: 前列腺, 穿刺, 疼痛, 麻醉, 氟比洛芬酯

Abstract: Objective: To examine the effects of perioperative intravenous administration of flurbiprofen axetil (FA) on pain associated with transrectal ultrasound-guided prostate biopsy. Methods: This was a randomized,controlled study. Eighty-one patients who underwent 12 core prostate biopsy were included in  the study. The patients were randomly assigned to one of three groups (n=27 in each) by type of procedure during prostate biopsy. Group intrarectal local anesthesia (IRLA) received intrarectal 5% (0.05 g/L) lidocaine gel 60 mg, 5 minutes before the procedure alone; Group FA received intravenous flurbiprofen axetil (1 mg/kg) 1 hour before the procedure;Group IRLA+FA received intrarectal 5% lidocaine gel 60 mg,  5 minutes before the procedure and intravenous flurbiprofen axetil (1 mg/kg) 1 hour before the procedure. The patients were asked to score the pain by using visual analogue scale (VAS) in 4 situations,including when the probe was inserted (VASⅠ),during anesthesia (VASⅡ),during biopsy (VASⅢ) and 20 minutes after biopsy (VASⅣ). The findings were evaluated with analysis of variance,and the Tukey post hoc test was followed with an overall 2-tailed significance level at α =0.05. P1, P value between Group IRLA and Group FA;P2, P value between Group FA and Group IRLA +FA,P3, P value between Group IRLA and Group IRLA +FA. The bonferroni method was used to adjust the test level, α=0.017,a P value of less than 0.017 was accepted as the threshold for statistical significance. Results: No major complications,including sepsis and severe rectal bleeding,were noted in any patient. There were no differences in general condition of the patients before procedure among the 3 groups. There were statistically significant differences in VAS scores among the 3 groups in VASⅡ (5.7±2.2, 3.0±1.5,3.3±1.9,respectively,P=0.012) and VASⅢ (6.7±2.3,3.0±2.1,2.9±1.6,respectively,P=0.001). There were no differences in the pain scores among the 3 groups during probe insertion (VASⅠ, 3.2±1.0,4.1±2.1,4.2±1.7, respectively,P=5.752) and 20 minutes after biopsy (VASⅣ, 1.4±2.1,1.0±0.9,1.1±0.7,respectively,P=3.772). Betweencolumn differences among the 3 groups were VASⅡ (P1=0.007,P2=5.655,P3=0.001,respectively) and VASⅢ(P1=0.008,P2=7.517,P3=0.001,respectively),the differences between Group IRLA and Group FA,Group IRLA and Group IRLA +FA in VASⅡ and VASⅢ were statistically significant. Conclusion:The intravenous flurbiprofen axetil was found to be more effective than intrarectal lidocaine gel alone.

Key words: Prostate, Biopsy, Pain, Anesthesia, Flurbiprofen axetil

中图分类号: 

  • R697+.3
[1] 白鹏, 张浩, 王洁初, 朱赫, 曾鸿. 合并肯尼迪病患者行膝关节置换术围术期管理1例[J]. 北京大学学报(医学版), 2026, 58(1): 225-227.
[2] 刘艳华, 陆敏, 赵旭阳, 张宽根, 武睿, 梅放, 戴志豪, 由江峰, 裴斐. 肿瘤转移抑制基因LASS2去磷酸化对液泡型ATP酶活性及前列腺癌侵袭性的影响[J]. 北京大学学报(医学版), 2025, 57(6): 1113-1123.
[3] 杨小勇, 张帆, 马潞林, 刘承. 前列腺导管腺癌临床特征及腺外侵犯的影响因素[J]. 北京大学学报(医学版), 2025, 57(5): 956-960.
[4] 宁家昕, 王浩然, 罗书航, 敬吉波, 王建业, 侯惠民, 刘明. 氧化应激相关基因与前列腺癌关系的多组学分析[J]. 北京大学学报(医学版), 2025, 57(4): 633-643.
[5] 王泽远, 于栓宝, 郑浩轲, 陶金, 范雅峰, 张雪培. 基于临床特征和多参数MRI的前列腺癌盆腔淋巴结转移的术前预测模型[J]. 北京大学学报(医学版), 2025, 57(4): 684-691.
[6] 刘杰, 马茗微, 王庆安, 石明, 尹金鹏, 王占平, 申静涛, 高献书. 基于锥形束CT的前列腺癌放射治疗两种体位固定方式摆位误差比较[J]. 北京大学学报(医学版), 2025, 57(4): 692-697.
[7] 左超, 王国立, 杨昆霖, 车新艳, 孟一森, 张凯. 前列腺体积不同的患者经尿道光纤铥激光前列腺剜除术的有效性及安全性比较[J]. 北京大学学报(医学版), 2025, 57(4): 711-716.
[8] 刘宁, 满立波, 何峰, 黄广林, 翟建坡. 良性前列腺增生患者排尿中断症状与尿动力学指标的相关性[J]. 北京大学学报(医学版), 2025, 57(2): 328-333.
[9] 刘慧丽, 闻蓓, 白雪, 陈明安, 李民. 体重校正腰围指数与疼痛的相关性:一项横断面研究[J]. 北京大学学报(医学版), 2025, 57(1): 178-184.
[10] 龙梅娟, 王怡丹, 武诗雅, 李梓豪, 李婷延, 李阳, 焦娟. 超重和肥胖对纤维肌痛综合征患者症状、整体病情及生活质量的影响[J]. 北京大学学报(医学版), 2024, 56(6): 1001-1008.
[11] 翟佳羽, 赵金霞, 安卓, 刘蕊. 低疾病活动度的中轴型脊柱关节炎患者残留症状评估及其相关因素分析[J]. 北京大学学报(医学版), 2024, 56(6): 987-993.
[12] 王军, 姚兰, 张宁, 索利斌, 李红培, 魏越, 查鹏, 梁正, 刘鲲鹏. 单侧胸椎旁阻滞对实施双腔气管插管患者血流动力学和意识水平的影响[J]. 北京大学学报(医学版), 2024, 56(5): 890-895.
[13] 李志存, 吴天俣, 梁磊, 范宇, 孟一森, 张骞. 穿刺活检单针阳性前列腺癌术后病理升级的危险因素分析及列线图模型构建[J]. 北京大学学报(医学版), 2024, 56(5): 896-901.
[14] 黄教悌,胡菁,韩博. 治疗相关神经内分泌前列腺癌机制研究与靶向治疗新进展[J]. 北京大学学报(医学版), 2024, 56(4): 557-561.
[15] 邢念增,王明帅,杨飞亚,尹路,韩苏军. 前列腺免活检创新理念的临床实践及其应用前景[J]. 北京大学学报(医学版), 2024, 56(4): 565-566.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!